Today's hearing marks the Health Subcommittee's first public discussion on modernizing the current system at the United States Food and Drug Administration to review, approve, and update over-the-counter drugs.
Burgess highlights the importance of modernizing FDA processes for over-the-counter drugs.
Share
More from Michael Burgess
I urge adoption of the amendment. It is important, with $31 trillion in national debt, that we be good stewards of taxpayer dollars. The gentleman is right. I have pursued this for a number of years, but it is because it is a noble cause…
I never expected that CMMI was actually going to deliver the cost savings that was promised.
I will simply underscore the fact that entry- level chemists at the EPA are hired at much higher than the GSA rate. These are not highly sought-after scientists. These are entry-level applicants, and there is no shortage of applicants for…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
Other voices in this conversation
